Why Pfizer's Q2 Earnings Results Might Be Weaker Than You'd Like

When Pfizer (NYSE:PFE) reported its first-quarter results in May, there were things to like -- but things to dislike, too. The big pharma company's earnings soared and topped Wall Street expectations. Revenue, however, came in lower than the consensus analysts' estimate.